The US Food and Drug Administration has approved a new nasal spray for depression treatment. Known as Spravato and ...

The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...

An asthma drug taken by hundreds of thousands of Australians could increase the risk of suicide, research suggests.

The U.S. Food and Drug Administration has approved a nasal spray that is known to help treat depression.

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

A one-time nasal spray has been approved by the Food and Drug Administration as a standalone treatment for depression.

"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...

A woman who suffered from severe migraines died after taking an overdose of a drug prescribed to treat them. Much-loved Katie ...

The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with ma ...

Johnson & Johnson has received FDA approval for Spravato nasal spray as the first and only monotherapy for adults with treatment-resistant depression.

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

The FDA has approved a supplemental new drug application for Spravato, an esketamine nasal spray that can be used as ...